Drug Development and Sports: The 10-Run Rule and Futility

Episode 59

0:00-51:59

In this episode of "In the Interim…", Dr. Scott Berry and Dr. Nick Berry investigate how futility in clinical trials and stopping rules in sports illuminate very similar decision problems, albeit with very different consequences. Drawing from baseball’s 10-run rule, tournament cuts in golf, the discussion confronts traditional and Bayesian strategies for interim decisions. The episode explains why simulation, not historical trial review, provides the empirical backbone for futility boundaries in clinical trials, and details the mechanics and consequences of aggressive stopping criteria. Using the Biogen aducanumab Alzheimer’s trials, the conversation exposes how a futility rule based on 20% predictive probability halted trials even when meaningful probability of success remained. Scott and Nick address the influence of ethical considerations, cost, regulatory priorities, and statistical rigor, and contrast Bayesian predictive probability’s strengths over conditional power.

Publisher

In the Interim...

Link

share.transistor.fm/s/2bbc6faf

Published

April 27, 2026

Duration

52 min

Format

Podcast

Category

Issues · Science

Source

RSS feed

Host

Berry

IT

In the Interim...

@intheinterim

#drugdevelopment #runrule #futility #mathematics #medicine

The Nile